{"prompt": "['2/11/22, 10:48 AM', 'Print: STUDY19020109 - TINA', 'PittPRO', 'Pitt Protocol', 'ClinicalTrials ID: NCT03577106', 'Review Online', 'Date: Friday, February 11, 2022 10:48:32 AM', 'Print', 'Close', 'View: Pitt SF: Basic Study Information 8.2', 'Basic Study Information', '1. * Title of study:', 'A Pilot fMRI Study of TMS in Late-Life Severe Worry', '2. * Short title:', 'TINA', '3.', '* Brief description:', 'We propose a study that will test a novel intervention through experimental', 'therapeutic approach. We plan to use fMRI-directed Intermittent Theta Burst', 'Stimulation (iTBS), a high frequency TMS paradigm, for the treatment of severe,', 'uncontrollable worry. While worry is a universal human experience, severe and', 'excessive worry has been recently linked to increased risk of stroke and other', \"cardiovascular diseases, increased risk of conversion to Alzheimer's disease as well\", 'as to higher risk of all-cause mortality in midlife and late-life. Severe, uncontrollable', 'worry has been repeatedly associated with reduced quality of life and impaired', 'functioning. Current treatment choices (antidepressant/anxiolytic medications and', 'psychotherapeutic interventions) have been proven moderately efficacious in', 'reducing anxiety/depression burden, but ineffective in reducing worry severity, a', 'phenomenon that may contribute to the high relapse rates associated with mood', 'and anxiety disorders. Our research indicated that worry severity is associated with', 'hyperactivation in specific regions such as orbital frontal cortex, superior parietal', 'gyrus, amygdala and parahippocampal gyrus. In this pilot study, we aim to explore', 'the efficacy of targeting one of these regions with iTBS. Based on our results, the', 'most accessible target is the right superior parietal gyrus (rSPG) - a region that', 'remained significantly associated with severe worry after controlling for effects of', 'comorbid depression or overall anxiety. As this region showed an increased in', 'cerebrovascular flow in association with worry severity, we propose to use iTBS', '(5x/week for 2 weeks) to modulate cortical plasticity in this region and consequently,', 'to reduce worry severity.', 'TMS during wakefulness has been shown to alter subsequent sleep [4], Further,', 'changes in sleep in response to TMS has been associated with how participants', 'respond to the TMS as a treatment [5]. Thus, we plan to measure sleep throughout', 'the protocol to determine whether sleep changes as a function of TMS and whether', 'sleep changes are associated with treatment response.', '4.', '* What kind of study is this?', 'Single-site study', '5.', '* Will an external IRB act as the IRB of record for this study?', 'Yes', 'No', '6.', '* Local principal investigator:', 'Carmen Andreescu', ' https://www.pittpro.pitt.edu/pittpro/sd/ResourceAdministration/Project/PrintSmartForms?Project=com.webridge.entity.Entity%5BOID%5BD27056B30D6913469B...', '1/63']['2/11/22, 10:48 AM', 'Print: STUDY19020109 - TINA', '*', 'Is this your first submission, as PI, to the Pitt IRB?', 'Yes', 'No', '7.', '*', 'Does the local principal investigator have a financial interest related to this', 'research?', 'Yes', 'No', '8. Attach the protocol:', 'Sponsor/Multicenter/Investigator-initiated protocol', 'Coordinating Center supplement', 'Emergency Use Consent/ Protocol/ FDA Form 3926', 'Exempt Application form', 'Document Category Date Modified Document History', 'There are no items to display', '  https://www.pittpro.pitt.edu/pittpro/sd/ResourceAdministration/Project/PrintSmartForms?Project=com.webridge.entity.Entity%5BOID%5BD27056B30D6913469B.', '2/63']\n\n###\n\n", "completion": "END"}